STOCK TITAN
  1. Home
  2. News
  3. BFLY

Butterfly Network Inc - BFLY STOCK NEWS

Welcome to our dedicated news page for Butterfly Network (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Butterfly Network's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Butterfly Network's position in the market.

News
Butterfly Network, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will report Q4 and full year 2023 financial results on February 28, 2024. An Investor Day is scheduled for March 18, 2024, at the New York Stock Exchange, showcasing the latest ultrasound technology and co-developed products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.19%
Tags
conferences earnings
-
News
Butterfly Network Launches Next-Generation Butterfly iQ3™ in the United States
Rhea-AI Summary
Butterfly Network, Inc. launches Butterfly iQ3, a third-generation handheld point-of-care ultrasound system powered by advanced semiconductor chip technology. The device offers unparalleled image quality, faster micro-beamforming, and new 3D imaging capabilities. Butterfly iQ3 is available for purchase in the United States at $3,899 plus membership, aiming to revolutionize point-of-care ultrasound with enhanced comfort, efficiency, and innovative tools.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.08%
Tags
none
-
News
Butterfly Network Provides Business Update During 42nd Annual J.P. Morgan Healthcare Conference Presentation
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) expects to exceed 2023 revenue and adjusted EBITDA guidance. The company showcased the sharp image quality of its newly FDA-cleared, third-generation probe, Butterfly iQ3, and introduced iQ Slice, the world’s first automated, sequential image capture mode on a handheld ultrasound, launching with Butterfly iQ3. Joseph DeVivo, Butterfly Network’s President, CEO, and Chairman, expressed confidence in the team's performance and energy, leading to the expectation of exceeding the 2023 guidance provided. The company’s previously issued guidance for the full year 2023 was revenue of at least $64 million, and an improved adjusted EBITDA loss of $75 - 70 million. Butterfly also announced FDA clearance of its next-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3, and expects to launch it this quarter (Q1 2024).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
none
News
Butterfly Network Announces FDA Clearance of its Next-Generation Handheld Ultrasound System, Butterfly iQ3
Rhea-AI Summary
Butterfly Network, Inc. (BFLY) announces FDA clearance for Butterfly iQ3, a next-generation handheld point-of-care ultrasound system. The new device features advanced semiconductor technology, improved image resolution, sensitivity, and penetration, as well as faster 3D capabilities. It also introduces novel, automated image capture modes: iQ Slice and iQ Fan. Butterfly iQ3 is set to revolutionize digital ultrasound and make it more accessible and approachable than ever before.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.79%
Tags
clinical trial
-
News
Butterfly to Participate at the 26th Annual Needham Growth Conference
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will host one-on-one investor meetings at the 26th Annual Needham Growth Conference on January 16, 2024. The company is a digital health company specializing in handheld, whole-body ultrasound and intuitive software.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
conferences
-
News
Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip™ Technology
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) and Mendaera partner to bring Butterfly’s Ultrasound-on-Chip™ to the robotic intervention market, with revenue anticipated from every unit sold. The partnership aims to streamline patient care by improving precision and consistency for a broad range of image-guided, needle-based interventions. FDA submission of the product is anticipated by 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.13%
Tags
none
News
Butterfly Network to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 8-11, 2024, in San Francisco. Joseph DeVivo, President & Chief Executive Officer, and Heather Getz, Executive Vice President & Chief Financial Officer, will present on January 11, 2024, at 9:00 AM PST. A webcast of the presentation will be available on the Butterfly investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.56%
Tags
conferences
-
News
Butterfly Network to Present at the Jefferies London Healthcare Conference
Rhea-AI Summary
Butterfly Network, Inc. (NYSE: BFLY) will participate at the Jefferies London Healthcare Conference on November 14-16, 2023. CEO Joseph DeVivo and CFO Heather Getz will present on November 14 at 3:30 PM GMT. A live webcast will be available on the Butterfly Network investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
News
Butterfly Network Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Butterfly Network, Inc. announced financial results for Q3 2023, reporting a total revenue of $15.4 million, down from $19.6 million in the same period last year. The company completed a cost reduction and reorganization, allowing them to extend their cash to 2026. Butterfly also announced a five-year co-development agreement with Forest Neurotech and the launch of Butterfly Garden, an AI marketplace. They introduced two new ultrasound education offerings and submitted iQ3 for FDA approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.58%
Tags
earnings
News
Butterfly Network Announces 5-Year Co-Development Agreement with Forest Neurotech for Next-generation Brain Computer Interfaces Using Ultrasound-on-Chip™ Technology
Rhea-AI Summary
Butterfly Network and Forest Neurotech announce a five-year co-development agreement to develop the first implanted, whole-brain neural interface. The deal includes $20MM in milestones paid to Butterfly, with additional revenue anticipated upon commercialization for every unit sold.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.78%
Tags
none
Stock BFLY logo
Butterfly Network Inc

NYSE:BFLY

BFLY Rankings

#3929 Ranked by Market Cap
#5382 Ranked by Stock Gains
N/A Ranked by Dividends

BFLY Stock Data

187.32M
152.61M
20.5%
37.34%
10.47%
Irradiation Apparatus Manufacturing
Manufacturing
Link
United States
Burlington

About BFLY

butterfly network operates at the cutting edge of multiple engineering and scientific disciplines and strives to bring together world-class talent in computer science, physics, and electrical engineering. the company is privately held and well funded by a small group of extraordinarily successful serial entrepreneurs. the company is in the rare position of being able to focus 100% of its efforts on product and intellectual property development rather than fundraising.